Tutorial on Health Economics and Outcomes Research in Nutrition
- 19 September 2014
- journal article
- research article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 38 (2S) , 5S-16S
Abstract
As healthcare costs climb around the world, public and private payers alike are demanding evidence of a treatment's value to support approval and reimbursement decisions. Health economics and outcomes research, or HEOR, offers tools to answer questions about a treatment's value, as well as its real‐world effects and cost‐effectiveness. Given that nutrition interventions have to compete for space in budgets along with biopharmaceutical products and devices, nutrition is now increasingly coming to be evaluated through HEOR. This tutorial introduces the discipline of HEOR and motivates its relevance for nutrition. We first define HEOR and explain its role and relevance in relation to randomized controlled trials. Common HEOR study types—including burden of illness, effectiveness studies, cost‐effectiveness analysis, and valuation studies—are presented, with applications to nutrition. Tips for critically reading HEOR studies are provided, along with suggestions on how to use HEOR to improve patient care. Directions for future research are discussed.Keywords
Funding Information
- Abbott Nutrition
This publication has 57 references indexed in Scilit:
- A Primer on Effectiveness and Efficacy TrialsClinical and Translational Gastroenterology, 2014
- Early enteral nutrition in critical illness: a full economic analysis using US costsClinicoEconomics and Outcomes Research, 2013
- The Budget Impact of Oral Nutritional Supplements for Disease Related Malnutrition in Elderly in the Community SettingFrontiers in Pharmacology, 2012
- Analysis of the health economic impact of medical nutrition in the NetherlandsEuropean Journal of Clinical Nutrition, 2010
- Instrumental variable methods in comparative safety and effectiveness researchPharmacoepidemiology and Drug Safety, 2010
- Systematic Review and Meta-analysis of Real-World Adherence to Drug Therapy for OsteoporosisMayo Clinic Proceedings, 2007
- Willingness to Pay for a Quality-adjusted Life YearMedical Decision Making, 2000
- Economic foundations of cost-effectiveness analysisJournal of Health Economics, 1997
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983
- Estimating the cost of illness.American Journal of Public Health and the Nations Health, 1967